您的位置: 首页 > 农业专利 > 详情页

TRAITEMENT DE LA MALADIE DE CROHN AU MOYEN DE LAQUINIMOD
专利权人:
Teva Pharmaceutical Industries Ltd.
发明人:
TARCIC, Nora,HAVIV, Asi,BLAUGRUND, Eran,KAYE, Joel
申请号:
MEP4916
公开号:
ME02414B
申请日:
2010.07.29
申请国别(地区):
ME
年份:
2016
代理人:
摘要:
This application provides for a method of treating a subject suffering from Crohn's disease, the method comprising periodically administering to the subject an amount of laquinimod or pharmaceutically acceptable salt thereof effective to treat the subject. This application provides for use of laquinimod in the manufacture of a medicament for treating a subject suffering from Crohn's disease. This application also provides for a pharmaceutical composition comprising laquinimod for use in treating a subject suffering from Crohn's disease.Predmetni pronalazak obezbeđujefarmaceutski preparat za upotrebu u lečenju pacijenta koji pati od Kronovebolesti, koji sadrži lakvinimod ili njegovu farmaceutski prihvatljivu so, akoji je delotvoran u lečenju pacijenta koji pati od Kronove bolesti.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充